Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125075212 | 12507521 | 2 | F | 20160107 | 20160627 | 20160629 | 20160707 | EXP | IT-ACTAVIS-2016-14259 | ACTAVIS | 73.08 | YR | M | Y | 0.00000 | 20160707 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125075212 | 12507521 | 1 | PS | Irinotecan | IRINOTECAN | 1 | Intravenous (not otherwise specified) | 340 MG, CYCLICAL | UNKNOWN | 78589 | 340 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||
| 125075212 | 12507521 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 3600 MG, CYCLICAL | UNKNOWN | 0 | 3600 | MG | SOLUTION FOR INFUSION | ||||||
| 125075212 | 12507521 | 3 | SS | AFLIBERCEPT | AFLIBERCEPT | 1 | Intravenous (not otherwise specified) | 340 MG, CYCLICAL | UNKNOWN | 0 | 340 | MG | |||||||
| 125075212 | 12507521 | 4 | C | LEDERFOLIN | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 280 MG, UNK | UNKNOWN | 0 | 280 | MG | SOLUTION FOR INFUSION | ||||||
| 125075212 | 12507521 | 5 | C | DIAMICRON | GLICLAZIDE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 6 | C | SIVASTIN | SIMVASTATIN | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 7 | C | TIKLID | TICLOPIDINE HYDROCHLORIDE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 8 | C | ADALAT | NIFEDIPINE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 9 | C | TRIATEC /00885601/ | RAMIPRIL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 10 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 11 | C | TENORMIN | ATENOLOL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 125075212 | 12507521 | 12 | C | SELEDIE | 2 | UNK | UNKNOWN | 0 | |||||||||||
| 125075212 | 12507521 | 13 | C | LASIX | FUROSEMIDE | 1 | UNK | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125075212 | 12507521 | 1 | Rectosigmoid cancer |
| 125075212 | 12507521 | 2 | Rectosigmoid cancer |
| 125075212 | 12507521 | 3 | Rectosigmoid cancer |
| 125075212 | 12507521 | 4 | Rectosigmoid cancer |
| 125075212 | 12507521 | 5 | Product used for unknown indication |
| 125075212 | 12507521 | 6 | Product used for unknown indication |
| 125075212 | 12507521 | 7 | Product used for unknown indication |
| 125075212 | 12507521 | 8 | Product used for unknown indication |
| 125075212 | 12507521 | 9 | Product used for unknown indication |
| 125075212 | 12507521 | 10 | Product used for unknown indication |
| 125075212 | 12507521 | 11 | Product used for unknown indication |
| 125075212 | 12507521 | 12 | Product used for unknown indication |
| 125075212 | 12507521 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125075212 | 12507521 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125075212 | 12507521 | Conjunctivitis | |
| 125075212 | 12507521 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125075212 | 12507521 | 1 | 20151001 | 0 | ||
| 125075212 | 12507521 | 2 | 20151001 | 0 | ||
| 125075212 | 12507521 | 3 | 20151001 | 0 | ||
| 125075212 | 12507521 | 4 | 20151001 | 20160121 | 0 |